CSI Market
Sign In | Register

Heron Therapeutics Inc (HRTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access HRTX Annual Balance Sheets →
From Heron Therapeutics Inc through Jun 30 2025, shifts in Jun 30 2026's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent42.70
Available-for-sale Securities, Debt Securities, Current MA21.94
Cash & Short-term Investments63.00
Accounts receivable89.57
Inventories90.59
Other Current Assets0.00
Prepaid Expense And Other Assets Current7.03
Total Current Assets229.85
Equipment/Property/Plant Net11.81
Other Assets, Noncurrent10.60
Operating Lease Right Of Use Asset-
Total Assets252.26
Liabilities
Accounts Payable, Current AC11.64
Employee-related Liabilities, Current AC6.63
Convertible Notes Payable, Current NO0.00
Other Liabilities, Current73.87
Total Current Liabilities92.15
Convertible Notes Payable, Noncurrent LO33.93
Total Long-term Debt33.93
Other liabilities, Noncurrent119.28
Accrued Clinical Liabilities25.17
Operating Lease Liability Current-
Non Current Notes Payable Excluding Convertible Notes Payable-
Total Liabilities245.35
Stockholders' Equity
Common Stock Value1.90
Additional Paid In Capital Common Stock1,957.36
Retained Earnings / Accumulated Deficit-1,953.39
Accumulated Other Comprehensive Income-0.01
Other Equity-0.01
Common Stockholder's Equity5.86
Preferred Stockholder's Equity1.05
Total Stockholder's Equity6.91
Liabilities & Stockholder's Equity252.26
4 historic quarters locked

Sign in to unlock the full Heron Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Heron Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-341301

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.